Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension

Nitric oxide synthases: structure, function and inhibition

ALDERTON, W. K., COOPER, C. E., & KNOWLES, R. G. (2001) · Biochemical Journal · doi:10.1042/bj3570593 · Cited by 4,110

Arginine metabolism: nitric oxide and beyond

WU, G., & MORRIS, S. M. (1998) · Biochemical Journal · doi:10.1042/bj3360001 · Cited by 2,811

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

Leone, A., Moncada, S., Vallance, P., Calver, A., & Collier, J. (1992) · The Lancet · doi:10.1016/0140-6736(92)90865-z · Cited by 2,107

Primary Pulmonary Hypertension

Rich, S., DANTZKER, D. R., AYRES, S. M., BERGOFSKY, E. H., BRUNDAGE, B. H., Detre, K. M., FISHMAN, A. P., GOLDRING, R. M., GROVES, B. M., KOERNER, S. K., et al. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-2-216 · Cited by 2,027

Primary Pulmonary Hypertension

Rubin, L. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701093360207 · Cited by 1,726

Reduced Expression of Endothelial Nitric Oxide Synthase in the Lungs of Patients with Pulmonary Hypertension

Giaid, A., & Saleh, D. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507273330403 · Cited by 1,366

Cellular and molecular mechanisms of endothelial cell dysfunction.

Harrison, D. G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119751 · Cited by 1,059

Mammalian nitric oxide synthases

Stuehr, D. J. (1999) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(99)00016-x · Cited by 996

Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN-containing flavoprotein.

Stuehr, D. J., Cho, H. J., Kwon, N. S., Weise, M. F., & Nathan, C. F. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.17.7773 · Cited by 816

Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine

Drexler, H., Zeiher, A. M., Meinzer, K., & Just, H. (1991) · The Lancet · doi:10.1016/0140-6736(91)92372-9 · Cited by 794

Metabolomics reveals serum metabolic signatures in H‐type hypertension based on mass spectrometry multi‐platform

Gao, S., Zhao, J., Liu, X., Liu, L., & Chen, R. (2023) · European Journal of Clinical Investigation · doi:10.1111/eci.14063 · Cited by 4

Inflammatory Mechanisms in the Pathogenesis of Pulmonary Arterial Hypertension

Chami, H. E., & Hassoun, P. M. (2011) · Comprehensive physiology · doi:10.1002/j.2040-4603.2011.tb00376.x · Cited by 4

Expression of key enzymes in the mevalonate pathway are altered in monocrotaline-induced pulmonary arterial hypertension in rats

Jiang, D., Chen, Y., Zhu, Y., Fu, G., & Xu, S. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7798 · Cited by 4

Nitric Oxide: Biological Synthesis and Functions

Förstermann, U., & Li, H. (2012) · Springer eBooks · doi:10.1007/978-3-642-30338-8_1 · Cited by 4

BK channels are indispensable for endothelial function in small pulmonary arteries

Guntur, D., Jeremic, D., Csáki, R., Myronenko, O., Biasin, V., Kolb, D., Michalick, L., Kuebler, W. M., Enyedi, P., Olschewski, H., et al. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02436-0 · Cited by 3

Exploring the interplay between mitochondria and endoplasmic reticulum in pulmonary arterial hypertension

Liao, Z., & He, Y. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1623775 · Cited by 3

Glycolysis in pulmonary arterial hypertension and metabolic reprogramming

Vasconcelos, I., Pérez‐Vizcaíno, F., Leite-Moreira, A. F., Brás‐Silva, C., & Adão, R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91704-9.00008-2 · Cited by 3

Pulmonary Vascular Remodeling: Cellular and Molecular Mechanisms

Stenmark, K. R., & Frid, M. G. (2010) · Springer eBooks · doi:10.1007/978-0-387-87429-6_52 · Cited by 3

Evaluation of ECG and echocardiographic findings in patients aged 2 to 18 years affected with thalassemia major

Alipour, M. R., Pezeshkpour, Z., Namayandeh, S. M., & Sarebanhassanabadi, M. (2021) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2021.101454 · Cited by 3

Serum metabolome alterations in hyperhomocysteinemia based on targeted and non-targeted MS-platforms

Zhao, X., Liu, X., Liu, L., & Chen, R. (2024) · Journal of Chromatography B · doi:10.1016/j.jchromb.2024.124336 · Cited by 3

Plasma l -citrulline concentrations in l -arginine–supplemented healthy dogs

Flynn, K., Kellihan, H. B., & Trepanier, L. A. (2017) · Journal of Veterinary Cardiology · doi:10.1016/j.jvc.2017.04.005 · Cited by 3

Novel Oral Prostacyclin Analog With Thromboxane Synthase Inhibitory Activity for Management of Pulmonary Arterial Hypertension

Tran, Q., & Watanabe, H. (2013) · Circulation Journal · doi:10.1253/circj.cj-13-0738 · Cited by 3

Mitochondrial arginase 2 regulates hematopoietic and cardiovascular adaptation to hypoxia

Xu, W., Asosingh, K., Janocha, A. J., Madden, E., Wanner, N., Trotter, D., Novotny, M., Mulya, A., Chen, R., Farha, S., et al. (2025) · Blood Vessels Thrombosis & Hemostasis · doi:10.1016/j.bvth.2025.100110 · Cited by 3

cAMP-enriched extracellular vesicles improve outcomes in pulmonary hypertension

Bhadra, A., Bonnie, F., Hewes, J. L., Patel, M., Lee, J., Zhou, C., & Bauer, N. N. (2026) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00239.2025 · Cited by 2

Hemostatic Alteration in Sickle Cell Disease

Alhawiti, N. M. (2021) · King Khalid University Journal of Health Sciences · doi:10.4103/kkujhs.kkujhs_7_21 · Cited by 2

Human Pulmonary Artery Endothelial Cells Increased Glycolysis and Decreased Nitric Oxide Synthase O-GlcNAcylation in Pulmonary Arterial Hypertension

Basehore, S. E., & Clyne, A. M. (2024) · International Journal of Translational Medicine · doi:10.3390/ijtm4010007 · Cited by 2

Exploring Novel Biomarkers for an Acute Coronary Syndrome Diagnosis Utilizing Plasma Metabolomics

Shibata, M., Sugimoto, M., Watanabe, N., & Namiki, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126674 · Cited by 2

Pulmonary Arterial Hypertension and Oxidative Stress

Chrobak, I., Haeger, C. M., Maracle, M., & Fredenburgh, L. E. (2014) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-1-4939-0497-6_15 · Cited by 2

Emerging Pathogenetic Mechanisms of Pulmonary Arterial Hypertension: Nitric Oxide and More

Kim, Y. D. (2011) · Korean Circulation Journal · doi:10.4070/kcj.2011.41.2.58 · Cited by 2

Things We “kNOw” and Do Not “kNOw” about Pulmonary Hypertension

Barnes, J. W., & Patel, R. P. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201803-0424ed · Cited by 2

Neonatal comorbidities and gasotransmitters

Gentle, S. J., Tipple, T. E., & Patel, R. P. (2020) · Nitric Oxide · doi:10.1016/j.niox.2020.01.012 · Cited by 2

RNA methylation, metabolic reprogramming and pulmonary hypertension

Hu, L., Shen, Y., Gan, X., Zhang, Y., Feng, Y., Wang, J., & Chen, F. (2023) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2023-0908 · Cited by 1

Metabolic reprogramming in pulmonary arterial hypertension

Shi, J.-Z., Ye, J., An, X.-R., Cheng, G., Fan, X., Meng, F.-F., Yang, O., Zhou, Y.-H.-Y., Zhang, M., Yuan, T., et al. (2026) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2026.109085 · Cited by 1

Nitric Oxide in Pathophysiology and Treatment of Pulmonary Hypertension

Maruyama, J., Yokochi, A., Zhang, E., Sawada, H., & Maruyam, K. (2013) · InTech eBooks · doi:10.5772/55680 · Cited by 2

INHALED NITRIC OXIDE: CLINICAL EFFECTS AND INFLUENCE ON THE PROFILE OF INFLAMMATORY MARKERS IN PATIENTS WITH IDIOPATHIC PULMONARY HYPERTENSION

Martynyuk, T. V., Наконечников, С. Н., Masenko, V. P., & Chazova, I. E. (2012) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2012-8-4-500-508 · Cited by 1

Pulmonary vascular remodeling and pathobiology of pulmonary hypertension

Morrell, N. W. (2011) · CRC Press eBooks · doi:10.1201/b13219-8 · Cited by 1

Lung Vascular Cell Heterogeneity

Stevens, T., Phan, S. H., Frid, M. G., Alvarez, D. F., Herzog, E. L., & Stenmark, K. R. (2012) · Proceedings of the American Thoracic Society · Cited by 1

Polyamines in Pulmonary Vascular Biology

Olson, J. W., & Gillespie, M. N. (2006) · Humana Press eBooks · doi:10.1007/978-1-59745-145-1_11 · Cited by 1

Riociguat: Stimulation der löslichen Guanylatzyklase

Leuchte, H., Behr, J., Ewert, R., Ghofrani, H. A., Grünig, E., Halank, M., Held, M., Klose, H. F. E., Rosenkranz, S., SCHERMULY, R. T., et al. (2015) · Pneumologie · doi:10.1055/s-0034-1391435 · Cited by 1

Physiological and Pathological Consequences of Vascular BMP Signaling

Benn, A., Haupt, J., Hildebrandt, S., Kaehler, C., & Knaus, P. I. (2017) · Springer eBooks · doi:10.1007/978-3-319-47507-3_17 · Cited by 2

Diffusional Control of Nitric Oxide in the Vessel Wall

Wood, K. C., Alvarez, R. A., & Straub, A. C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804273-1.00018-1 · Cited by 1

Pulmonary Vascular Pathophysiology

Rabinovitch, M. (2012) · doi:10.1002/9781444398786.ch5 · Cited by 1

NITRIC OXIDE AND NITROGEN OXIDES

Meurs, H., Maarsingh, H., & Zaagsma, J. (2006) · Elsevier eBooks · doi:10.1016/b0-12-370879-6/00265-9 · Cited by 1

Nitric oxide synthase 3 and endothelin 1 immunoreactivity in pulmonary hypertension

Vaideeswar, P., & Gupta, R. K. (2010) · Indian Journal of Pathology and Microbiology · doi:10.4103/0377-4929.68270 · Cited by 1

Inflammation and remodelling in experimental models of COPD - Mechanisms and therapeutic perspectives

Pera, T. (2011) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 1

Platelet Interactions with the Blood Vessel Wall

Maron, B. A., & Loscalzo, J. (2017) · Springer eBooks · doi:10.1007/978-3-319-47462-5_29 · Cited by 1

Hypoxia responses in arginase 2 deficient mice enhance cardiovascular healthPreprint

Xu, W., Asosingh, K., Janocha, A. J., Madden, E., Wanner, N., Trotter, D., Novotny, M., Mulya, A., Farha, S., & ERZURUM, S. C. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.20.639297 · Cited by 1

Estudo de marcadores de disfunção endotelial e de inflamação em portadores de hipertensão arterial pulmonar: implicações terapêuticas e prognósticas

Barreto, A. C. (2011) · doi:10.11606/t.5.2011.tde-27022012-094417

Manipulation of the insulin-like growth factor 1 receptor on the vascular endothelium : the effect on whole body and endothelial specific insulin sensitivity

Gatenby, V. K. (2014) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)

The role of arginine in human wound healing

Debats, I. B. J. G. (2011) · doi:10.26481/dis.20110923id

Papel del óxido nítrico en la fisiologïa normal de la vía aérea y sus implicaciones en la fisiopatología de la hipertensión pulmonar

Chinchilla, M., Bolívar, F., Luengas, C., Rincón, M. Y., Bolivar, I., & López-Jaramillo, P. A. (2008) · Redalyc (Universidad Autónoma del Estado de México)

Pulmonal-endotheliale Dysfunktion bei chronischer Linksherzinsuffizienz

Kerem, A. (2011) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-4887

Pathology, Pathobiology and Pathophysiology of Pulmonary Arterial Hypertension

Rabinovitch, M. (2013) · Springer eBooks · doi:10.1007/978-1-4471-4619-3_202

Prenatal Arginase Changes and Fetal Oxygenation~!2009-12-12~!2010-03-16~!2010-05-04~!

Ivanecky, I., & Belik, J. (2010) · The Open Nitric Oxide Journal · doi:10.2174/1875042701002020077

Mecanismos moleculares e celulares envolvidos na modulação da via L-arginina-óxido nítrico em hipertensão e insuficiência renal crônica

Moss, M. B. (2010) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)

Protective effect of regular aerobic training on inflammatory and toxicity markers of lung tissue in L-NAME-induced hypertension

Heidarzadeh (2012) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2012.2810

Inhaled nitric oxide and nitric oxide donors

Machado, R. F. (2011) · CRC Press eBooks · doi:10.1201/b13219-32

Serum l-Arginase in Healthy Subjects and Nitric Oxide

Ogino, K., & Takemoto, K. (2016) · Springer eBooks · doi:10.1007/978-3-319-26009-9_14

The Role of Innate Immunity in the Pathogenesis and Treatment of Experimental Pulmonary Hypertension

Ormiston, M. L. (2006) · TSpace (University of Toronto)

Serial Review: Redox Signaling in Immune Function and Cellular Responses in Lung Injury and Diseases Serial Review Editors: Victor Darley-Usmar, Lin Mantell Role of epithelial nitric oxide in airway viral infection ☆

Xu, W., Zheng, S., Dweik, R. A., & ERZURUM, S. C. (2006)

Evaluation of Endothelial Nitric Oxide Synthase Gene Expression in Mice Genetically Heterozygous in CX43 (CX43 + / - Mice)

Obaalologhi, W. (2018) · International Journal of Scientific and Research Publications · doi:10.29322/ijsrp.8.10.2018.p8267

Effect of Oral Administration of Honey on Arginase Activity of Rats Exposed to Smoke

Ezima, E. N., Oyefuga, O. H., Fagbohunka, B. S., Adeyanju, M. M., Alabi, M. A., & Onayemi, A. A. (2016)

Apoptotic cell-derived factors induce arginase II expression in murine macrophages by activating ERK5/CREB

Ag, S. B. (2011)

Arginine as A Potential Therapy against Ischemic/Reperfusion Injury in Rat Model

Debopriya, G. D., Sandeep, M. D., & Rajkumar, R. (2022) · International Journal of Pharma and Bio Sciences · doi:10.22376/ijpbs.2022.13.1.b29-36

Nitric Oxide and Nitrogen Oxides

Maarsingh, H., Scott, J. A., & Grasemann, H. (2021) · Elsevier eBooks · doi:10.1016/b978-0-08-102723-3.00102-5

The role of L-Arginine in cardiovascular system

Sudar-Milovanovic, E. M., Obradovic, M. M., Bajić, V., Bogdanović, N., Radak, Đ., & Isenović, E. R. (2015) · Medicinska istrazivanja · doi:10.5937/medist1501036s

MITOMYCIN C IN THE TREATMENT OF URETHRIC STRICTURE AND ITS EFFECT ON ARGINASE/NO-SYNTHASE SYSTEM

Шеремета, Д. Р., Свердан, О. П., Vorobets, D. Z., Фафула, Р. В., & Vorobets, Z. D. (2022) · Bulletin of Problems Biology and Medicine · doi:10.29254/2077-4214-2022-2-1-164-276-287

Nitazoxanide reverses pulmonary vascular remodeling in pulmonary hypertension by targeting the IMPA1-RAGE signaling axis

Wang, D., Huang, N., Cai, M., Huang, R., Zhu, X., & Hu, C.-P. (2025) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2025.117657

Tetrahydrobiopterin And Pulmonary Hypertension

Zhao, L., Bahaa, F., & Wilkins, M. R. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6300-8_5

Rôles clinico-biologiques du monoxyde d'azote produit par les voies aériennes

Tadié, J. (2010) · doi:10.70675/abd56c0fz6366z441fzb38fze313a5431d89

Dysfonctions vasculaire et bronchique dans deux modèles de bronchopathies chroniques inflammatoires chez l’homme : tabagisme et mucoviscidose. Voies de l’endothéline-1 et de la balance NOS/arginases

Henno, P. (2010) · theses.fr (ABES) · doi:10.70675/b7c8c142zbdb9z4cb2zb3a6zf1e5fa920946

Sénescence cellulaire et nouvelles approches thérapeutiques de l'hypertension artérielle pulmonaire

Mouraret, N. (2013) · theses.fr (ABES) · doi:10.70675/b2ae892dzafc0z4b55z9d55zb8908a6a07c7

Mécanismes de régulation de la hème-oxygénase-1 et de la cyclooxygénase-2 par les statines dans les macrophages et les fibroblastes

Mrad, M. F. (2013) · doi:10.70675/862aa8e1z3e04z4d65zb92az9f759aa785f1

Coopération entre les isoformes TAp73 et la signalisation TGF-β dans la régulation de l'expression de la NO Synthase inductible

Cabrié, A. (2017) · theses.fr (ABES) · doi:10.70675/df567380z9a01z4262z9a43z7666c8df7b0f

Rôle du remodelage de la matrice extracellulaire dans la reprogrammation des cellules vasculaires pulmonaires au cours de l'hypertension artérielle pulmonaire

Rachedi, N. (2024) · doi:10.70675/ce19657cz09dez41d0z9ffezca0d3b10b914

Kinetics and molecular docking studies of the inhibition of arginase by lupin seed protein-derived peptides

Chukwuejim, S., Oluwajuyitan, T. D., Kadam, D., Fatoki, T. H., & Aluko, R. E. (2026) · Journal of Functional Foods · doi:10.1016/j.jff.2026.107499

Arginase in vascular disease: Mechanisms, measurement, and medicine

Durante, W. (2026) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2026.09.053

BindingDB Entry 50038395: N(delta)-Methylated L-arginine derivatives and their effects on the nitric oxide generating system.

BindingDB (2012) · UC San Diego · doi:10.7270/q2kw5gxn

Caracterização farmacológica do ativador da guanilato ciclase solúvel, BAY 60-2770, em artéria pulmonar isolada de coelho

Faria, W. M. (2013) · doi:10.47749/t/unicamp.2013.915106

Arginine Metabolic Endotypes in Pulmonary Arterial Hypertension

Kao, C. C., Wedes, S. H., Hsu, J. W.-C., Bohren, K. M., COMHAIR, S. A. A., Jahoor, F., & ERZURUM, S. C. (2015) · Pulmonary Circulation · doi:10.1086/679720 · Cited by 56

Nitrite in pulmonary arterial hypertension: therapeutic avenues in the setting of dysregulated arginine/nitric oxide synthase signalling

Zuckerbraun, B. S., George, M. P., & Gladwin, M. T. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq370 · Cited by 99

Roles of accumulated endogenous nitric oxide synthase inhibitors, enhanced arginase activity, and attenuated nitric oxide synthase activity in endothelial cells for pulmonary hypertension in rats

Sasaki, A., Doi, S., Mizutani, S., & Azuma, H. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00360.2006 · Cited by 62

Nitric oxide and pulmonary arterial pressures in pulmonary hypertension

Machado, R. F., Nerkar, M.-V. L., Dweik, R. A., Hammel, J., Janocha, A. J., Pyle, J., Laskowski, D. M., Jennings, C. A., Arroliga, A. C., & ERZURUM, S. C. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.06.039 · Cited by 87

Pulmonary Arterial Hypertension in Rats Due to Age-Related Arginase Activation in Intermittent Hypoxia

Nara, A., Nagai, H., Shintani‐Ishida, K., Ogura, S., Shimosawa, T., Kuwahira, I., Shirai, M., & Yoshida, K.-I. (2014) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2014-0163oc · Cited by 30